[Paradoxical response to antitubercular treatment in patients with human immunodeficiency virus infection].
Olalla
J
J
Unidad de Infección VIH. Hospital Universitario Doce de Octubre, Madrid.
Pulido
F
F
D019380:Anti-HIV Agents / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000009:adverse effects* / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D003937:Diagnosis, Differential; D018450:Disease Progression; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology; D016867:Immunocompromised Host; D014376:Tuberculosis / Q000150:complications / Q000188:drug therapy*; D018088:Tuberculosis, Multidrug-Resistant / Q000175:diagnosis
D019380:Anti-HIV Agents; D000995:Antitubercular Agents